Estimating healthcare resource needs for COVID-19 patients in Nigeria.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2020
Historique:
received: 10 09 2020
accepted: 17 09 2020
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 9 3 2021
Statut: epublish

Résumé

continuous assessment of healthcare resources during the COVID-19 pandemic will help in proper planning and to prevent an overwhelming of the Nigerian healthcare system. In this study, we aim to predict the effect of COVID-19 on hospital resources in Nigeria. we adopted a previously published discrete-time, individual-level, health-state transition model of symptomatic COVID-19 patients to the Nigerian healthcare system and COVID-19 epidemiology in Nigeria by September 2020. We simulated different combined scenarios of epidemic trajectories and acute care capacity. Primary outcomes included the expected cumulative number of cases, days until depletion resources and the number of deaths associated with resource constraints. Outcomes were predicted over a 60-day time horizon. in our best-case epidemic trajectory, which implies successful implementation of public health measures to control COVID-19 spread, assuming all three resource scenarios, hospital resources would not be expended within the 60-days time horizon. In our worst-case epidemic trajectory, assuming conservative resource scenario, only ventilated ICU beds would be depleted after 39 days and 16 patients were projected to die while waiting for ventilated ICU bed. Acute care resources were only sufficient in the three epidemic trajectory scenarios when combined with a substantial increase in healthcare resources. substantial increase in hospital resources is required to manage the COVID-19 pandemic in Nigeria, even as the infection growth rate declines. Given Nigeria's limited health resources, it is imperative to focus on maintaining aggressive public health measures as well as increasing hospital resources to reduce COVID-19 transmission further.

Identifiants

pubmed: 33654515
doi: 10.11604/pamj.2020.37.293.26017
pii: PAMJ-37-293
pmc: PMC7881931
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

293

Informations de copyright

Copyright: Adeteju Ogunbameru et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Sci Total Environ. 2020 Aug 10;729:138959
pubmed: 32375067
CMAJ. 2020 Jun 15;192(24):E640-E646
pubmed: 32409519
BMJ Glob Health. 2020 May;5(5):
pubmed: 32434777
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
CMAJ. 2020 May 11;192(19):E497-E505
pubmed: 32269018

Auteurs

Adeteju Ogunbameru (A)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.

Kali Barrett (K)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
University Health Network, Toronto, Ontario, Canada.

Arinola Joda (A)

Department of Clinical Pharmacy and Biopharmacy, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria.

Yasin Azim Khan (YA)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
University Health Network, Toronto, Ontario, Canada.

Petros Pechlivanoglou (P)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
Child Health Evaluative Sciences, The Hospital for Sick Children (SickKids) Research Institute, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.

Stephen Mac (S)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.

David Naimark (D)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Raphael Ximenes (R)

Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
Escola de Matemática Aplicada, Fundação Getúlio Vargas, Rio de Janeiro, Brazil.

Beate Sander (B)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
University Health Network, Toronto, Ontario, Canada.
ICES, Toronto, Ontario, Canada.
Public Health Ontario, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH